However, a majority (56.2%) of patients either remained around the same weight they were at when stopping the medication or continued to lose additional weight
The Phase 2a MASLD readout published in Nature Medicine in 2024 reported dose-dependent reductions in liver fat content across the same dose range (Sanyal et al., Nature Medicine, 2024)
Meanwhile, according to Grand View Research, the GLP-1 market stood at roughly $53 billion in 2024 and is forecast to reach $157 billion by 2030
Helps fade freckles and uneven skin tone
The growth hormone-releasing combination (CJC-1295 + Ipamorelin) supports fat metabolism, muscle preservation, sleep quality, and hormonal health while BPC-157 handles tissue repair and anti-inflammation
Additionally, studies have reported potential mild, transient increases in serum cortisol levels, particularly at higher doses